An interventional study of TARGET in Patient Readmission, sponsored by Insel Gruppe AG, University Hospital Bern. Completed at 4 sites in Switzerland. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-01-26.
Sponsored by Insel Gruppe AG, University Hospital Bern · Not applicable, Interventional, and Health services research
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Hospital rehospitalizations within 30 days are frequent and represent a burden for the patients, but also for the entire health care system. This study evaluates the impact of an intervention targeted to high-risk medical patients in order to reduce their risk of rehospitalization. Half of the patients will receive a set of interventions before and after their hospital discharge, while the other half will receive usual care.
Background: Hospital readmissions within 30 days are frequent, with rates varying usually between 12 and 20%. Is it therefore recognized as important to improve the quality of the transition of care period in order to avoid as much as possible hospital readmissions. There are however still several gaps in current knowledges. First, most trials to reduce hospital readmission have been performed on specific patient populations such as patients with diabetes or heart failure, and therefore the findings may not be well generalizable to other high-risk population. Second, while some specific interventions have been showed to reduce readmission, these were complex and resources demanding, and no trial targeted these interventions to the patients who are most likely to benefit for better effectiveness, using a widely validated prediction tool, such as the "HOSPITAL" score. Finally, most studies tested unimodal interventions instead of more promising multimodal interventions.
Specific aim: the goal of this proposal is to evaluate the effect of a multimodal transitional care intervention prioritized to higher-risk medical patients on the composite of 30-day unplanned readmissions and death.
Methods: the investigators will conduct a multicenter randomized controlled trial in medical inpatients discharged home or nursing home, who are identified as having a higher risk for 30-day readmission. Risk of readmission will be predicted using the simplified HOSPITAL score, which includes 6 variables routinely available before hospital discharge and which has been previously validated in more than 200,000 patients across 6 countries in its original version, and in nearly 120,000 patients in its simplified version. Patients will be randomly assigned to the intervention group or usual care group. The primary outcome will be the first 30-day unplanned readmission or all-cause mortality. The primary analysis will be a comparison between two groups according to the intention-to-treat principle.
308 studies on the registry are indexed under Patient Acceptance of Health Care; 53 are open to participants now.
This study's enrollment of 1,393 is above the median of 201 across 217 interventional studies indexed under Patient Acceptance of Health Care.
Browse Patient Acceptance of Health Care studies →Insel Gruppe AG, University Hospital Bern is the lead sponsor of 741 studies on the registry; 179 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
The intervention group will receive a standardized transition care intervention by a trained nurse composed of a pre-discharge component and 2 post-discharge follow-up phone calls 3 days and 14 days after discharge.
Other: TARGET
The group control will receive usual care without additional intervention.
The pre-discharge component includes mainly patient information, medication reconciliation, patient education, planning of a first post-discharge primary care physician visit with a timely discharge summary sent to the primary care physician. Two follow-up phone calls are made by a nurse, at D3 and D14, and include the assessment of the general health condition, the verification of the follow-up care plan, a reinforcement of the patient education, and review with the patient of the medication list with assessment of potential adverse drug events.
30-day unplanned readmission or death
Number of patients who have a first unplanned readmission or die within 30 days after discharge (Composite endpoint).
Time frame: 30 days after hospital discharge
First 30-day unplanned readmission
Number of patients who have a first unplanned readmission (individual components of the primary composite outcome)
Time frame: 30 days after hospital discharge
30-day mortality
Number of patients who die (individual components of the primary composite outcome).
Time frame: 30 days after hospital discharge
Time to first unplanned readmission or death
Number of days between hospital discharge and first unplanned readmission or death.
Time frame: Within 30 days after hospital discharge
Patient's perspective (satisfaction) on quality of transition of care between hospital and home
Proportion of patients who are responding positively to all 3 items of the Three-Item Care Transition Measure (CTM-3)
Time frame: 30 days after hospital discharge
Post-discharge health care utilization 1
Total number of readmission(s)
Time frame: 30 days after hospital discharge
Post-discharge health care utilization 2
Total number of days of hospitalizations within 30 days
Time frame: 30 days after hospital discharge
Post-discharge health care utilization 3
Number of emergency room visits
Time frame: 30 days after hospital discharge
Post-discharge health care utilization 4
Number of primary care provider visits
Time frame: 30 days after hospital discharge
Main cause of readmission or death
Proportion of most frequent main diagnosis for the readmission
Time frame: 30 days after hospital discharge
Costs of readmission
Total costs of the rehospitalization in Swiss Francs (CHF)
Time frame: 30 days after hospital discharge
PDFs hosted by the registry, ClinicalTrials.gov.
Ran from Apr 2018 to primary completion in Feb 2020, 22 months.
Of 151 non-industry interventional studies with no phase under Patient Acceptance of Health Care, half reached primary completion within 19 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 35. This study's 22 months is above that.
Counting every sponsor, half of 154 studies reached it within 19 months; a quarter within 8 and three quarters within 34.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Patient Acceptance of Health Care →
Insel Gruppe AG, University Hospital Bern →